Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma
scientific article published on 21 March 2008
Author/s
author: Henry Seth Friedman, Sridharan Gururangan, Annick Desjardins, Allan Friedman, David A Reardon, Roger E McLendon, Jeremy N Rich, Jennifer J Quinn, James J Vredenburgh, Merrill J. Egorin, Sith Sathornsumetee, James H. Herndon, Theodore F Lagattuta, August Salvado
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.